Background -As P adrenoceptor dys-
that age related P adrenoceptor changes are important in the pathogenesis of late onset asthma in old age. Methods -Subjects were non-smokers who comprised 17 young normal subjects of mean (SE) age 29'4 (1-3) years, 17 elderly normal subjects of 67-2 (1-3) years, seven young asthmatic patients of 31P0 (2 8) years, and 17 elderly asthmatic patients of 68-5 (14) years. All asthmatic patients withheld inhalers for 12 hours and oral treatment for 24 hours before each study day. Subjects underwent an inhaled methacholine challenge (Newcastle dosimeter method) on two nonconsecutive days. The slope of the flow at 50% of the vital capacity (FEF,O) doseresponse curve was derived from the percentage fall in FEF50 divided by methacholine dose (sFEF50). Beta-adrenoceptor density (Bmax) and affinity (%KH) were determined with (125I)iodocyanopindolol as the radioligand in membranes prepared from mononuclear leucocytes.
Results -Log sFEF50 was shown to be reproducible (repeatability coefficient 0-41) on the two study days and was inversely related to %KH but not to Bmax. Multiple regression analysis (all 58 subjects, overall R2=0 57) revealed an inverse relation between log sFEFSO and %KH, and between log sFEF,4 and Bmax. The inverse relation between log sFEFSO and %KH was preserved whereas that between log sFEF50 and Bmax was lost when young asthmatic subjects or when all asthmatic subjects were excluded from multiple regression analysis.
Conclusions -The P adrenoceptor dysfunction observed in late onset asthma may be similar to that seen during ageing. Thus late onset asthma may represent the extreme of a spectrum of age associated P adrenoceptor dysfunction. (Thorax 1994; 49:26-32) In elderly patients asthma has a prevalence of at least 6-5% and is often unrecognised.' 2 Although most elderly asthmatic patients first develop asthma in adulthood,' the pathogenesis of late onset asthma is poorly understood. Reduced ,B adrenoceptor responsiveness is seen in young asthmatic patients' and in normal elderly subjects.9'3 Increased non-specific bronchial responsiveness, determined by methacholine or histamine challenge, is characteristic of asthma, its degree correlating with the severity of the asthma.' '6 Beta-receptor dysfunction has long been postulated as a cause of increased non-specific bronchial responsiveness and of asthma itself. '7 This should imply an increasing prevalence of high levels of non-specific bronchial responsiveness with increasing age, and a relation between the degree of 1 adrenoceptor function and the level of non-specific bronchial responsiveness. However, evidence of the former is confusing,1827 and the latter hypothesis has been little investigated. 2728 We have examined the hypothesis that age related 1 adrenoceptor dysfunction occurs in late onset asthma by assessing: (1) mononuclear leucocyte membrane P adrenoceptor density and affinity in elderly, late onset asthmatic and elderly non-asthmatic subjects, and in young asthmatic and non-asthmatic subjects; and (2) the relation between non-specific bronchial responsiveness to methacholine and the above in vitro indices of 1 adrenoceptor function in all four subject groups.
Methods

SUBJECTS
Healthy young (18-50 years) and elderly (60-85 years) non-asthmatic subjects, and young (22-42 years) and elderly (60-85 years) asthmatic subjects who were otherwise healthy were recruited from the community. Sixteen of the healthy young subjects had participated in a previous study using an identical protocol29 and their data are included for comparison with the other groups. In addition, data on the sensitivity of the neutrophil respiratory burst to inhibition by isoproterenol in many of the subjects have been reported previously.30 Table 1 gives subject characteristics for each group. Asthmatic subjects were those with variable respiratory symptoms and documented 20% variability in forced expiratory volume in one second (FEVI), either spontaneously or following a single dose of inhaled 1 agonist. Non-asthmatic (normal) subjects had Repeatability is expressed as the ratio of the slope on Day I to that on Day 2 a plotted against the geometric mean of the pair. The ratios did not differ signific6 from unity. The solid horizontal line indicates the overall geometric mean and t broken horizontal lines represent the geometric mean plus or minus two standarc deviations which constitute the 95% limits for repeat sFEF,0 determination.
Results
RESPONSE TO METHACHOLINE
Elderly asthmatic subjects had a lower bN FEV1 (% predicted) than young norma jects (p < 0-0001), elderly normal su (p < 00001), and young asthmatic su (p < 0-001). To evaluate reproducibility response to methacholine, for each subj ratio of the simplified slope of FEF50. (sFEF50.Day 1) to sFEF50.Day 2 on a lo, (equivalent to difference of the logs on a scale) was plotted against the geometric of the pair on a log scale (equivalent to log sFEF50 on a linear scale). The ratios c differ significantly from unity ( fig 1) geometric means of sFEF50 on Days 1 were 237 8% fall/mg (95% confidence for mean 113-3 to 499 5°% fall/mg) and 2 fall/mg (95% confidence limits for mean to 442-8% fall/mg), respectively. The gc ric mean of the ratios of sFEF50.Da3 related to %KH (fig 2) . To evaluate further relative importance of factors that might expected to influence the response to met choline, multiple regression analysis was p formed with log sFEF50 as the dependent v; able (table 4) . Data from all 58 subjects w used for these analyses. Log sFEF50 showe significant inverse relation with both % (p<0005) and Bmax (p<0005), with a h coefficient of multiple regression.
inversely ------------------------------------------------------------------------------
When multiple regression analysis i repeated in normal subjects only (table 5) , inverse relationship between log sFEF50 . %KH was preserved (p<0 05), but t between log sFEF50 and Bmax was lost. Sii lar results were obtained with multiple regr sion in young and elderly normal subjects . elderly asthmatic subjects (that is, exclud young asthmatic subjects, table 6). Since ANOVA comparing elderly normal and elderly asthmatic subjects had only demonstrated a trend towards an intergroup difference in %KH, a further multiple regression analysis was performed for these 34 subjects only. It showed significant relations between log sFEF50 and baseline FEV1 (p < 00005) and %KH (p < 005), but not between log sFEF50 and Bmax.
No overall relation was shown between any -in vitro variable and baseline lung function. 100 For young or elderly asthmatic patients there was no relation between any in vitro variable the and either duration of asthma or age of onset or between log sFEF50 and asthma duration or age of onset. the be :ha-Discussion per-This study has confirmed the reduction in ari-mononuclear leucocyte membrane 3 adrenorere ceptor affinity with preservation of receptor d a density in normal elderly men and women. KH More importantly it has shown that, in comigh parison with young and elderly normal subjects, mononuclear leucocytes from elderly, was late onset asthmatic patients have further the reductions in affinity without a reduction in and receptor density. Indeed, there was an inverse that correlation between non-specific bronchial remi-sponsiveness (a marker of asthma severity) and res-receptor affinity, but not between non-specific and bronchial responsiveness and receptor density. ling These abnormalities in receptor affinity were not seen in young asthmatic patients, although in this latter group the previously described reductions in receptor density compared with 58 young normal subjects were confirmed. Young asthmatic patients were also found to have lower receptor density than elderly asthmatic patients.
Multiple regression analysis employing an index of bronchial responsiveness as the dependent variable showed an inverse relation between responsiveness and both receptor Itiple affinity and receptor density when all subjects were included in the analysis. When young asthmatic subjects were excluded, however, the relation between responsiveness and densn ity was lost but the inverse relation between responsiveness and affinity was preserved. This was also true if only normal subjects were included in the analysis, strongly suggesting that the relation is a function of age (or ageing) rather than of asthma. Taken together these results suggest that the tiple mechanism or mechanisms responsible for 1 adrenoceptor dysfunction in late onset asthma are similar to those underlying age-associated ,B adrenoceptor dysfunction, and distinct from those associated with juvenile onset asthma. If true, then late onset asthma may represent the far end of a spectrum of age-associated I adrenoceptor dysfunction. Although there is controversy as to the adequacy of the mononuclear leucocyte model in terms of the degree to which it reflects changes in airway j adrenoceptors, in vitro and in vivo ltiple abnormalities of f adrenoceptor function are well recognised in young asthmatics'8 and 
vivo abnormalities have been described in normal elderly subjects9-'3 and may be a consequence of the effects of ageing on the I adrenergic receptor adenylyl cyclase system. Nevertheless, the limitations of the mononuclear leucocyte model must be acknowledged.
Lymphocytes and lung membranes of young asthmatic subjects have reduced numbers (density) of f3 adrenoceptors.568 In contrast, normal elderly subjects have normal lymphocyte membrane receptor density'339 41 but reduced receptor affinity for agonist.'3 This is thought to represent functional uncoupling of the receptor from the adenylyl cyclase complex, and is associated with impaired receptormediated adenylyl cyclase activity.4243 Impaired adenylyl cyclase activity is common to asthma and normal ageing.4' '244 The pos sibility that late onset asthma represents the extreme end of a spectrum of ageing effects on the 3 adrenoceptor pathway has not previously been examined, and in vitro studies on 0 receptors of elderly asthmatic subjects have not been reported.
It has been suggested that P adrenoceptor dysfunction in ageing is due to downregulation by endogenous catecholamines."1 13 The higher resting noradrenaline levels in the elderly normal and elderly asthmatic subjects in this study are in general agreement with previous literature. ' 1345 Our failure to show a relation between noradrenaline levels and either receptor affinity or non-specific bronchial responsiveness level argues against the downregulation hypothesis.
The present finding of a greater degree of bronchial responsiveness in elderly normal than in young normal subjects is entirely consistent with the hypothesis of an association between late onset asthma (and therefore hyperresponsiveness) and age-associated ,B adrenoceptor dysfunction. There is, however, disagreement in the literature as to the effect of age on non-specific bronchial responsiveness. Some studies have indeed suggested a higher level of responsiveness in the elderly19-22 while others have found no effect of age. '8 2336 In some of these latter cases, however, few or no subjects over 65 years were studied.'82335
Others2426 examined the percentage of subjects with hyperresponsiveness (as opposed to absolute level of responsiveness) and at least one24 showed a trend towards hyperresponsiveness at the extreme end of the age range. A recent paper which again failed to show an ageassociated increase in airway reactivity included only two of 85 subjects over 70 years.27
The young normal subjects in this same study displayed a surprisingly large range of nonspecific bronchial responsiveness, measured as FEVI slope (over 400 fold, as opposed to 14 fold in the present study), and yet repeatability of their non-specific bronchial responsiveness measurement was not assessed. Two recent large studies4647 report conflicting data on the effects of age on bronchial responsiveness in non-smokers.
There are three potential pitfalls with the novel hypothesis of the model of late onset asthma as an age-associated receptor-mediated disease. Firstly, we were unable to study large numbers of drug naive elderly asthmatic subjects. Thus, chronic treatment with inhaled f agonists may be implicated in downregulation of 3 adrenoceptors. While this may partially explain our results, it would not explain why the receptor abnormality shown was exclusively one of reduced affinity, whereas similar studies on treated young asthmatics have shown reduced receptor density.8 Furthermore, it has been shown in older patients with chronic obstructive pulmonary disease that treatment with ,B agonists leads to a fall in density but not in agonist affinity in mononuclear leucocytes. 48 Secondly, the methacholine challenge itself (Day 1) may have affected in vitro ,B adrenoceptor parameters (Day 2). Exposure of guinea pigs to high doses of inhaled acetylcholine for one week reduces 3 adrenoceptor density in the lung membrane.49 However, affinity was unchanged and systemic I adrenoceptors were not examined.49 Thus, even if -as seems unlikely -systemic P adrenoceptors were affected by one methacholine challenge two days before sampling, changes in density rather than affinity would be expected, with the greatest changes occurring in subjects receiving the largest methacholine dose (young normals). Such an effect would blunt rather than produce or exaggerate the differences seen in our study.
The third and most important criticism of the suggestion that I adrenoceptor ageing plays a major part in the pathogenesis of late onset asthma is quantitative rather than qualitative. Although acute intravenous f blockade potentiates non-specific bronchial responsiveness in young non-asthmatic subjects,50 the potentiation is small (up to fourfold), whereas our elderly asthmatic patients possessed a degree of non-specific bronchial responsiveness 2000 times that of young normal subjects. However, this is likely to represent an oversimplification of the pathophysiology of chronic f adrenoceptor dysfunction. The ,B adrenergic system also modulates cholinergic neurotransmission at a prejunctional level with effects upon endogenous acetylcholine sensitivity up to 100 times more potent than its effects on response to exogenous cholinergic agents.5' Further, acute intravenous 3 blockade would not produce immediate effects via other f adrenergic-dependent mechanisms such as lung microvascular leakage, alveolar permeability, surfactant secretion, inhibition of mast cell mediator release and neutrophil lysozyme secretion, and stimulation of ciliated epithelial function.52 Modulation of any of these systems could be expected to result in changes in bronchial responsiveness. Indeed, late asthmatic responses, which are paralleled by increases in non-specific bronchial responsiveness,53 are associatd with bronchial oedema and the release of prostaglandins, leukotrienes, and other mediators from mast cells and other sources. Furthermore, increases in epithelial permeability do enhance non-specific bron-chial responsiveness,54 and chronic asthma is associated with neutrophil accumulation in the airway and chronic oedema. 55 We also showed the value of the methacholine challenge approach for the study of airway function in ageing. The methacholine challenge technique used for this study is well established.3' The use of FEF50 as the ventilatory parameter was dictated by the need to obtain measurable bronchoconstriction in non-asthmatic subjects, and it is the small airway parameter which changes least with age. 56 Expression of results as the simplified slope of the dose-response curve has been validated previously for FEV,. 37 The present study has shown its use with FEF50 to produce reproducible results (comparing favorably with more conventional indices using the same dosimeter in both young and elderly subjects31 57), which discriminated well between subject groups. Our overall conclusion is that age-associated reduction in adrenoceptor affinity for agonist ( 
